ストックスクリーナーアプリを入手
4.03
2.18%
-0.09
前日終値:
$4.12
開ける：
$4.21
24時間の取引高:
684
Relative Volume:
0.08
時価総額：
$6.00M
収益：
$5.67M
当期純損益:
$-13.98M
株価収益率:
-0.2852
EPS:
-14.13
ネットキャッシュフロー:
$-15.30M
1週間 パフォーマンス:
-6.28%
1か月 パフォーマンス:
+27.94%
6か月 パフォーマンス:
+4.40%
1年 パフォーマンス:
+50.37%
1日の値動き範囲:
$4.04
$4.21
1週間の範囲:
$3.50
$4.86
52週間の値動き範囲:
$2.40
$10.31
Arcadia Biosciences Inc Stock (RKDA) Company Profile
名前
Arcadia Biosciences Inc
電話
530-756-7077
住所
202 COUSTEAU PLACE, DAVIS, CA
RKDA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
4.05 | 6.00M | 5.67M | -13.98M | -15.30M | -14.13 |
|
KHC
Kraft Heinz Co
|
27.19 | 33.61B | 25.43B | 2.66B | 3.03B | 2.19 |
|
GIS
General Mills Inc
|
53.02 | 29.88B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
81.81 | 28.64B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
73.69 | 20.04B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.01 | 16.03B | 11.91B | 756.75M | 890.57M | 1.37 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-08-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-12 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2015-06-09 | 開始されました | Credit Suisse | Outperform |
| 2015-06-09 | 開始されました | Piper Jaffray | Overweight |
Arcadia Biosciences Inc (RKDA) 最新ニュース
SEC Form 4 filed by Chief Financial Officer Kawakami Mark - Quantisnow
SEC Form 4 filed by Chief Executive Officer Schaefer Thomas J. - Quantisnow
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com - Defense World
Arcadia Biosciences Reports Strong Growth Amid Challenges - TipRanks
Arcadia Biosciences: Q1 Earnings Snapshot - New Haven Register
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and ... - Yahoo Finance
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and Strategic Moves Amid Challenges - GuruFocus
Earnings call transcript: Arcadia Biosciences sees Q1 2025 revenue rise 22% - Investing.com
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Arcadia Biosciences Q1 Earnings Preview - MSN
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Arcadia Climbs on Q1 Figures - Baystreet.ca
ARCADIA BIOSCIENCES Earnings Results: $RKDA Reports Quarterly Earnings - Nasdaq
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights | RKDA Stock News - GuruFocus
Arcadia Biosciences, Inc. SEC 10-Q Report - TradingView
Arcadia Biosciences reports Q1 revenue $1.2M vs $987k last yea - TipRanks
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Geode Capital Management LLC Takes $73,000 Position in Arcadia Biosciences, Inc. (NASDAQ:RKDA) - Defense World
Halper Sadeh LLP, Arcadia Biosciences, Inc., The Interpublic Group of Companies, Inc., Omnicom Group Inc., Enterprise Bancorp, Inc. - Olean Times Herald
Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com - Defense World
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 - GuruFocus
Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule - Nasdaq
Arcadia Biosciences (RKDA) Announces Date of First Quarter - GlobeNewswire
Mark Your Calendar: Arcadia Biosciences to Reveal Q1 2025 Financial Performance on May 8 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Arcadia Biosciences regains IP rights, amends agreement By Investing.com - Investing.com India
Arcadia Biosciences regains IP rights, amends agreement - Investing.com
Arcadia Biosciences IncEnters Agreement To Transfer Patents And Rights With A Third Party- SEC Filing - MarketScreener
Head-To-Head Contrast: Lendway (NASDAQ:LDWY) versus Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter
Arcadia Biosciences (NASDAQ:RKDA) vs. Lendway (NASDAQ:LDWY) Critical Analysis - Defense World
Arcadia Biosciences Inc. (RKDA) reports earnings - qz.com
Arcadia Biosciences outlines 2025 growth potential for Zola after 46% sales increase in 2024 - MSN
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock - MSN
Arcadia Biosciences Earnings Call Highlights Zola Growth - TipRanks
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Call Highlights: Strong Zola Sales Propel ... - Yahoo Finance
Arcadia Biosciences Reports Strong Revenue Growth in 2024 - TipRanks
Earnings call transcript: Arcadia Biosciences Q4 2024 sees revenue growth By Investing.com - Investing.com Canada
Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow
Arcadia Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Arcadia Biosciences Inc (RKDA) 財務データ
収益
当期純利益
現金流量
EPS
Arcadia Biosciences Inc (RKDA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Schaefer Thomas J. | Chief Executive Officer |
Feb 03 '25 |
Buy |
2.49 |
700 |
1,743 |
2,819 |
| Kawakami Mark | Chief Financial Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
1,981 |
| Schaefer Thomas J. | Chief Executive Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
2,119 |
0.90%
大文字化:
|
ボリューム (24 時間):